首页> 外国专利> Crystalline form II of dextral oxiracetam, preparation method therefor and use thereof

Crystalline form II of dextral oxiracetam, preparation method therefor and use thereof

机译:右旋奥拉西坦的晶型Ⅱ,其制备方法和用途

摘要

The present invention provides a crystalline form of dextral oxiracetam. The crystalline form has a diffraction peak when a diffraction angle, 2θ, is 17.76±0.2°, 20.16±0.2°, 21.20±0.2°, 24.17±0.2°, or 25.88±0.2°. The crystalline form of dextral oxiracetam can promote synthesis of phosphorylcholine and phosphoethanolamine, boosts cerebral metabolism, has a stimulating function on a specific central nervous pathway through a blood-brain barrier, and has special biological activity in the field of sedation and the antiepileptic field. The crystalline form of dextral oxiracetam of the present invention is a water-containing crystalline form, contains 0.5 water molecules, loses crystallization water at 73.5±2° C., and is melted and decomposed at 138.0±2° C. The crystalline form of dextral oxiracetam of the present invention can stably exist at room temperature and relative humidity of 0-95%, does not transform, is used for storage and formulation processing, and has low requirements for processing or storage humidity.
机译:本发明提供了右旋奥拉西坦的结晶形式。当衍射角2θ为17.76±0.2°,20.16±0.2°,21.20±0.2°,24.17±0.2°或25.88±0.2°时,该结晶形式具有衍射峰。右旋奥拉西坦的结晶形式可以促进磷酸胆碱和磷酸乙醇胺的合成,促进脑部新陈代谢,通过血脑屏障对特定的中枢神经通路具有刺激作用,并且在镇静和抗癫痫领域具有特殊的生物活性。本发明的右旋奥拉西坦的晶体形式是含水的晶体形式,含有0.5个水分子,在73.5±2℃下失去结晶水,并且在138.0±2℃下熔融并分解。本发明的右旋奥拉西坦在室温和0-95%的相对湿度下可以稳定存在,不变形,用于储存和配制加工,对加工或储存的湿度要求低。

著录项

  • 公开/公告号US10793521B2

    专利类型

  • 公开/公告日2020-10-06

    原文格式PDF

  • 申请/专利权人 CHONGQING RUNZE PHARMACEUTICAL COMPANY LIMITED;

    申请/专利号US201716344338

  • 发明设计人 LEI YE;

    申请日2017-07-07

  • 分类号C07D207/273;A61P25/08;A61K31/4015;

  • 国家 US

  • 入库时间 2022-08-21 11:28:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号